3 CYCLES OF CHEMOTHERAPY FOLLOWED BY PRIMARY CYTOREDUCTIVE SURGERY FOR UNRESECTABLE OVARIAN-CANCER

被引:1
作者
GUIDOZZI, F
SONNENDECKER, EWW
机构
关键词
D O I
10.1016/0090-8258(91)90043-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Definitive primary cytoreductive surgery was achieved at second laparotomy after three cycles of combination chemotherapy (cisplatin and cyclophosphamide) in three patients who presented with unresectable disease at our Ovarian Tumor Unit. The ovarian cancer was inoperable at the first laparotomy and no surgical procedure was performed other than biopsy of malignant tumor to confirm the diagnosis. Following interventional surgical cytoreduction the patients were given a further six courses of combination chemotherapy and then maintained for a further six cycles on oral chlorambucil. Two patients are disease free at 17 and 21 months, respectively, while the other patient has cytological evidence of malignancy but no other clinically detectable tumor deposits at 27 months. © 1991.
引用
收藏
页码:313 / 316
页数:4
相关论文
共 19 条
[1]   ASSESSMENT OF MORBIDITY AND MORTALITY IN PRIMARY CYTOREDUCTIVE SURGERY FOR ADVANCED OVARIAN-CARCINOMA [J].
CHEN, SS ;
BOCHNER, R .
GYNECOLOGIC ONCOLOGY, 1985, 20 (02) :190-195
[2]   CISPLATIN, METHOTREXATE, AND 5-FLUOROURACIL COMBINATION CHEMOTHERAPY FOR ADVANCED OVARIAN-CANCER [J].
CONTE, PF ;
SERTOLI, MR ;
BRUZZONE, M ;
RUBAGOTTI, A ;
ROSSO, R ;
BENTIVOGLIO, G ;
CONIO, A ;
PESCETTO, G .
GYNECOLOGIC ONCOLOGY, 1985, 20 (03) :290-297
[3]  
DEVITA VT, 1971, CANC CHEMOTHER REP 3, V3, P23
[4]  
EINTHORN N, 1985, CANCER, V55, P2019
[5]  
GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727
[6]   THE INFLUENCE OF CYTOREDUCTIVE SURGERY ON PROGRESSION-FREE INTERVAL AND SURVIVAL IN EPITHELIAL OVARIAN-CANCER [J].
HOSKINS, WJ .
BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY, 1989, 3 (01) :59-71
[7]   PREOPERATIVE IRRADIATION IN STAGE-3 CARCINOMA OF OVARY [J].
KJORSTAD, KE ;
WELANDER, C ;
KOLSTAD, P .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1977, 56 (04) :449-452
[8]   RADIOTHERAPY IN THE TREATMENT OF OVARIAN CARCINOMA [J].
KOTTMEIER, HL .
CLINICAL OBSTETRICS AND GYNECOLOGY, 1961, 4 (03) :865-874
[9]  
LAWTON FG, 1989, OBSTET GYNECOL, V73, P61
[10]   RANDOMIZED TRIAL COMPARING 2 COMBINATION CHEMOTHERAPY REGIMENS (CHAP-5 V CP) IN ADVANCED OVARIAN-CARCINOMA [J].
NEIJT, JP ;
TENBOKKELHUININK, WW ;
VANDERBURG, MEL ;
VANOOSTEROM, AT ;
WILLEMSE, PHB ;
HEINTZ, APM ;
VANLENT, M ;
TRIMBOS, JB ;
BOUMA, J ;
VERMORKEN, JB ;
VANHOUWELINGEN, JC .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (08) :1157-1168